The invention provides compounds of general formula (I) that inhibit selected kinases (Pirn and/or CK.2 kinases) and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, and certain infections and immunological disorders.